Understanding PRDM8-Related Disorders
At a Glance
PRDM8-related disorders are ultra-rare genetic conditions affecting the nervous system. Symptoms can progress along a seizure-and-jerking or stiffness-and-weakness pattern, and brain-wave changes may occur without seizures. Care is individualized because no standard treatment protocol has been established.
Receiving a diagnosis of a PRDM8-related disorder can feel like being handed a map to a territory that has barely been explored. Because this condition is so exceptionally rare, you may find that you are learning about it alongside your doctors. This page is designed to help you orient yourself to what is currently known about this ultra-rare condition and to validate the complex journey you or your family member are beginning.
The Reality of Extreme Rarity
As of the 2022 medical literature, PRDM8-related disorders are among the rarest genetic conditions reported in the world. Only a few families have been documented globally, including one family from Pakistan and a second family from Iran [1].
In a world where many rare diseases have thousands of patients and dedicated foundations, an “ultra-rare” diagnosis like this means there is no standard “playbook.” Local medical providers—including general pediatricians and even some neurologists—will likely have never seen a case of PRDM8-related disorder before [1]. This lack of familiarity is not a reflection of your doctor’s skill; it is simply a result of the condition’s extreme rarity.
A Wide Clinical Spectrum
Research shows that mutations in the PRDM8 gene do not look the same in every person. Instead, they exist on a spectrum of neurological symptoms that can mimic more common conditions. Doctors often describe this spectrum using two main clinical “anchors” reported so far:
- Progressive Myoclonus Epilepsy-like (PME): Some individuals present with a “Lafora-like” condition [1]. Myoclonus refers to sudden, involuntary muscle jerks, and PME involves a combination of these jerks, seizures, and a gradual decline in cognitive and motor skills over time [2].
- Complicated Hereditary Spastic Paraplegia-like (cHSP): Other individuals may first show signs of spasticity (muscle stiffness) and weakness in the legs, which is characteristic of HSP [1]. When this is “complicated,” it means it is accompanied by other neurological issues, such as balance problems (ataxia) or cognitive changes [3].
Interestingly, some patients may show abnormal electrical activity on an EEG (electroencephalogram, a test that measures brain waves) known as generalized epileptiform discharges [1]. It is important to know that an interictal (between-seizure) discharge is an EEG pattern; it is not automatically a clinical seizure, does not necessarily cause damage, and does not automatically require treatment [1].
Understanding the Biological Mechanism
The PRDM8 gene provides instructions for making a protein that acts as a “master regulator” in the nervous system. It belongs to a family of proteins that control how other genes are turned on or off by modifying chromatin (the material that packages DNA) [4].
Research in animal models has provided hypotheses to help scientists understand why PRDM8 is so vital, though these do not prove the exact mechanism of progression in human patients:
- Brain Development: In mouse models, Prdm8 is essential for the proper development of the neocortex, the part of the brain responsible for higher-order functions like sensory perception and cognition. Knockout models showed growth delays [5].
- Cellular Identity: In zebrafish models, researchers found that prdm8 helps determine whether cells in the spinal cord become motor neurons or support cells called oligodendrocytes [6].
When the PRDM8 gene is mutated, these regulatory processes are disrupted. This likely leads to the progressive neurological symptoms seen in patients, as the brain and nervous system may not develop or function with the stability they require [6][5].
Reported Findings vs. Unanswered Questions
Because so few cases exist, medical consensus is still evolving. Here is a summary of the current landscape based on the few reported families:
| Reported Findings | What Remains Uncertain |
|---|---|
| PRDM8 is a critical regulator of brain development and gene expression [4][5]. | The exact “natural history” (how the disease progresses over decades) and life expectancy are not yet fully understood. |
| The condition is progressive, meaning symptoms may change or become more pronounced over time [1]. | Why some present with seizures (PME) while others present with leg stiffness (HSP) is unknown [1]. |
| EEG abnormalities can be present even without visible physical seizures [1]. | There is no single “gold standard” treatment protocol specifically for PRDM8; care is currently focused on symptoms. |
Moving Forward
Living with an ultra-rare diagnosis requires a shift in perspective. You are not just a caregiver or patient; you are a vital member of the clinical team. Every observation you make contributes to the growing body of knowledge about PRDM8-related disorders. Connecting with genetic counselors to discuss variant classification, inheritance, family testing, and carrier status is an important step.
Because of the potential for depression and anxiety when dealing with rare neurological conditions, it is important to ensure that you and your family have access to mental health support [7]. Connecting with global rare disease networks and specialized neurogenetics centers may help you find the expertise that local clinics may lack.
Common questions in this guide
What is a PRDM8-related disorder?
What symptoms can PRDM8-related disorders cause?
Does an abnormal EEG mean a person is having seizures?
How do PRDM8-related disorders resemble progressive myoclonus epilepsy or hereditary spastic paraplegia?
Is there a standard treatment for a PRDM8-related disorder?
What is known about progression and life expectancy?
How can families get support after a PRDM8-related diagnosis?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Genetic counseling
Can a genetic counselor explain what this diagnosis means for my family?
Mental health support
Could I get mental health support while we learn about this condition?
Specialist referrals
Could a specialized neurogenetics center help with my care?
Get notified when new evidence is published on PRDM8-related progressive myoclonus epilepsy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (7)
- 1
The second family affected with a PRDM8-related disease.
Davarzani A, Shahrokhi A, Hashemi SS, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(6)):3847-3855 doi:10.1007/s10072-021-05815-w.
PMID: 35034233 - 2
Lafora body disease: a case of progressive myoclonic epilepsy.
Kaur R, Balaini N, Sharma S, Sharma SK
BMJ case reports 2020; (13(12)) doi:10.1136/bcr-2020-236971.
PMID: 33370974 - 3
Children with suspected hereditary spastic paraplegia clearly benefit from whole exome analysis.
Safka Brozkova D, Paulasova Schwabova J, Vyhnalkova E, et al.
Human genomics 2026; (20(1)).
PMID: 41749354 - 4
The Roles of the PRDM Family in the Neuro-Motor System.
Deng S, Li H, Feng J, et al.
Biomolecules 2026; (16(4)) doi:10.3390/biom16040497.
PMID: 42072619 - 5
Deletion of Prdm8 impairs development of upper-layer neocortical neurons.
Inoue M, Iwai R, Yamanishi E, et al.
Genes to cells : devoted to molecular & cellular mechanisms 2015; (20(9)):758-70 doi:10.1111/gtc.12274.
PMID: 26283595 - 6
Prdm8 regulates pMN progenitor specification for motor neuron and oligodendrocyte fates by modulating the Shh signaling response.
Scott K, O'Rourke R, Gillen A, Appel B
Development (Cambridge, England) 2020; (147(16)) doi:10.1242/dev.191023.
PMID: 32680935 - 7
The epidemiology of hereditary spastic paraplegia and associated common mental health outcomes in England and Northern Ireland.
Jeyakumar H, Chandan JS, Nirantharakumar K, Lee SI
Orphanet journal of rare diseases 2025; (20(1)):326 doi:10.1186/s13023-025-03849-3.
PMID: 40598191
This page is for informational purposes only and does not constitute medical advice; it cannot predict an individual’s course. Discuss genetic testing, EEG findings, treatment, and monitoring with your neurologist and genetics team.